quinoxalines has been researched along with thymidine in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (25.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Branda, RF; McCormack, JJ; Perlmutter, CA | 1 |
Makoff, A; Waring, M | 1 |
Dunegan, CM; English, AR | 1 |
Bauer, PM; Buga, GM; Fukuto, JM; Ignarro, LJ; Wei, LH | 1 |
Jongsma, J; Noordzij, MA; Oomen, MH; Romijn, JC; Schröder, FH; van Der Kwast, TH; van Steenbrugge, GJ | 1 |
Daval, JL; Grojean, S; Koziel, V; Vert, P | 1 |
Amann, K; Apel, TW; Oberhauser, V; Ritz, E; Rump, LC; von Kügelgen, I; Vonend, O | 1 |
Chawla, PS; Kochar, MS | 1 |
Mai, L; Wei, Q; Yao, A; Zhang, D; Zhang, Z; Zhou, Q | 1 |
Liu, H; Wei, Q; Zhang, D; Zhang, Z; Zhou, H; Zhou, Q | 1 |
Liu, H; Wei, Q; Zhang, D; Zhou, Q | 1 |
Qian, T; Wang, Z; Yang, R; Yuan, Y; Zhou, Q | 1 |
1 review(s) available for quinoxalines and thymidine
Article | Year |
---|---|
What's new in clinical pharmacology and therapeutics.
Topics: Abatacept; Acetanilides; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiparkinson Agents; Antirheumatic Agents; Antiviral Agents; Apomorphine; Benzazepines; Cardiovascular Agents; Fumarates; Hepatitis B; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hypoglycemic Agents; Immunoconjugates; Multiple Sclerosis; Natalizumab; Nucleosides; Papillomavirus Vaccines; Pharmacology, Clinical; Piperazines; Pyrazines; Pyrimidinones; Quinoxalines; Ranolazine; Sitagliptin Phosphate; Smoking Cessation; Telbivudine; Thymidine; Triazoles; Varenicline; Viral Vaccines | 2008 |
11 other study(ies) available for quinoxalines and thymidine
Article | Year |
---|---|
Cellular pharmacology of chloroquinoxaline sulfonamide and a related compound in murine B16 melanoma cells.
Topics: Animals; Cell Division; Cell Line; Chromatography, High Pressure Liquid; Deoxyuridine; DNA; Flow Cytometry; Leucovorin; Melanoma; Mice; Quinoxalines; Sulfanilamides; Sulfaquinoxaline; Tetrahydrofolate Dehydrogenase; Thymidine | 1988 |
Breakdown of pulse-labeled ribonucleic acid and polysomes in Bacillus megaterium: actions of streptolydigin, echinomycin, and triostins.
Topics: Anti-Bacterial Agents; Bacillus megaterium; Centrifugation, Density Gradient; Dactinomycin; DNA, Bacterial; Filtration; Half-Life; Isotope Labeling; Peptides, Cyclic; Phosphorus Radioisotopes; Polyribosomes; Protoplasts; Pyrans; Pyrrolidinones; Quinoxalines; RNA, Bacterial; Sucrose; Thymidine; Tritium | 1974 |
Quinoxaline-1, 4-di-N oxides. I. Inhibition of deoxyribonucleic acid synthesis in Escherichia coli by 2,3-dihydroxymethyl-quinoxaline-1, 4-di-N-oxide.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon Isotopes; Depression, Chemical; DNA, Bacterial; Escherichia coli; Leucine; Oxides; Quinoxalines; RNA, Bacterial; Thymidine; Uracil | 1970 |
NG-hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms.
Topics: Animals; Aorta; Arginase; Arginine; Caco-2 Cells; Cell Division; Coculture Techniques; DNA; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Donors; Ornithine; Ornithine Decarboxylase; Oxadiazoles; Polyamines; Putrescine; Quinoxalines; Rats; Spermidine; Spermine; Thymidine; Triazenes; Urea | 1998 |
Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines.
Topics: Androgens; Cell Division; Cyclic AMP; Dideoxyadenosine; Enzyme Inhibitors; Gastrin-Releasing Peptide; Humans; Male; Neuropeptides; Oxadiazoles; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Quinoxalines; Thymidine; Tumor Cells, Cultured | 2000 |
Bilirubin induces apoptosis via activation of NMDA receptors in developing rat brain neurons.
Topics: Animals; Apoptosis; Bilirubin; Caspases; Cells, Cultured; Cycloheximide; Cysteine Proteinase Inhibitors; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Fluorescent Dyes; Indoles; Male; Neurons; Oligopeptides; Pregnancy; Prosencephalon; Protein Kinase C; Protein Synthesis Inhibitors; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Thymidine; Tritium | 2000 |
ATP release in human kidney cortex and its mitogenic effects in visceral glomerular epithelial cells.
Topics: Adenosine Triphosphate; Adrenergic alpha-Agonists; Brimonidine Tartrate; Cell Division; Cells, Cultured; Electric Stimulation; Epithelial Cells; Gene Expression; Humans; Kidney Cortex; Kidney Failure, Chronic; Kidney Glomerulus; MAP Kinase Signaling System; Mitogens; Norepinephrine; Organ Culture Techniques; Quinoxalines; Receptors, Purinergic P2; Reverse Transcriptase Polymerase Chain Reaction; Sympathetic Nervous System; Thymidine; Tritium | 2002 |
Design, synthesis, and in vitro and in vivo biological studies of a 3'-deoxythymidine conjugate that potentially kills cancer cells selectively.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Proliferation; Drug Design; Fluorescence; Humans; Liver; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mitochondria; Molecular Structure; Neoplasms; Quinoxalines; Superoxides; Thymidine; Tumor Cells, Cultured | 2012 |
Anticancer activity of a thymidine quinoxaline conjugate is modulated by cytosolic thymidine pathways.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytosol; Disease Models, Animal; Gene Expression; Gene Silencing; Humans; Liver Neoplasms; Male; Metabolic Networks and Pathways; Mice; Neoplasms; Quinoxalines; Thymidine; Thymidine Kinase; Thymidine Phosphorylase; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Structure-activity relationship study of anticancer thymidine-quinoxaline conjugates under the low radiance of long wavelength ultraviolet light for photodynamic therapy.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Screening Assays, Antitumor; Humans; Photochemotherapy; Quinoxalines; Reactive Oxygen Species; Structure-Activity Relationship; Thymidine; Ultraviolet Rays | 2016 |
Naphthyl quinoxaline thymidine conjugate is a potent anticancer agent post UVA activation and elicits marked inhibition of tumor growth through vaccination.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Quinoxalines; Structure-Activity Relationship; Thymidine; Ultraviolet Rays; Vaccination | 2019 |